Specific aims are to assess the role of ketosis in reducing glycemia during VLCD treatment of obese NIDDM and to determine the efficacy of a more ketogenic VLCD to achieve greater and more rapid glycemic control in obese NIDDM. The data from this protocol is being retained on the CDMAS for completion and future use.
Showing the most recent 10 out of 509 publications